My DyslipidemiaXpert

[space]	Find documents with all the words specified. dopamine homeostasis will get documents with dopamine and homeostasis, found documents must contain the two elements.
OR	Find documents with at least one of the words specified. dopamine OR homeostasis will get documents with word dopamine or homeostasis.
-	The sign - exclude the documents with word or expression specified. dopamine - homeostasis will get the documents with dopamine but without homeostasis. The sign - must be used with others operators.
" "	Find the documents with exactly the expression between the two quotation marks. Example: "symptomatic medication" will find only the documents with "symptomatic medication" in the document.
( )	Brackets are used to group words in a sub expression: (dopamine homeostasis) OR (ergotamine headache)
*	Asterisk is the truncation operator. It can be used as a prefix (with quotation marks) or suffix. *dopa homeo, dopne or "cature"*.

What's new in DyslipidemiaLast update of the site: Tuesday, 21 January 2020

What is new in lipid‐lowering therapies in diabetes?

Yee‐Ming Cheung et al. | Internal Medicine Journal 2019; 49(12):...

Diabetes confers an independent risk to cardiovascular disease (CVD) but also shares many common comorbidities...

Read article

Meta-Analysis of the Relation of Body Mass Index to Cardiovascular Outcomes...

Khan, Safi U. et al. | The American Journal of Cardiology 2019;...

The impact of body mass index (BMI) on cardiovascular outcomes among patients receiving intensive low-density...

Read article

Lipid lowering and Alzheimer disease risk: A mendelian randomization study

Dylan M. Williams PhD et al. | Annals of Neurology 2020; 87(1): 30-9...

There are no preventive or disease‐modifying treatments for Alzheimer disease (AD). Expanding the...

Read article

Effects of intensive lipid-lowering therapy on mortality after coronary bypass...

Alkhalil et al. | Atherosclerosis 2019; 293(-): 75-8

The recent reported analysis from the ODYSSEY OUTCOMES trial showed that patients with previous coronary...

Read article

Statin use and the risk of renal cell carcinoma: national cohort study

Yu-Ching Chou et al. | Journal of Investigative Medicine 2019;...

The statins are currently the most commonly prescribed lipid-lowering agents that are widely used in...

Read article

Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without...

Masuda, Daisaku et al. | Atherosclerosis 2019; 292(-): 163-70...

We aimed to investigate blood lipid and lipoprotein profiles in patients with dyslipidemia receiving...

Read article

Interrupted time series analysis on first cardiovascular disease hospitalization...

Feiyu Hu et al. | Pharmacoepidemiology and Drug Safety...

Cardiovascular disease (CVD) is a globally leading cause of death, accounting for 17.9 million deaths...

Read article

Application of non-HDL cholesterol for population-based cardiovascular risk...

Brunner, Fabian J et al. | The Lancet 2019; 394(10215): 2173-83...

The relevance of blood lipid concentrations to long-term incidence of cardiovascular disease and the...

Read article

Statin therapy: does sex matter?

Faubion, Stephanie S.MD et al. | Menopause 2019; 26(12): 1425-35

Statins refer to a class of drugs originally approved by the US Food and Drug Administration (FDA) for...

Read article

Phytosterol compositions of enriched products influence their cholesterol-lowering...

Ying Jie et al. | European Journal of Clinical Nutrition...

According to data from the Word Health Organization (WHO), cardiovascular diseases (CVD) remain the leading...

Read article

Read more
More scientific & medical news in your area of expertise

Prevalence of Dyslipidemia in Undiagnosed Palestinian Men: A Cross-Sectional Study

Ali Iyad et al. | Journal of Lipids 2019 (2019), Article... Read article

Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP)

Opoku Sampson et al. | BMC Public Health 2019; 19(1): 1443 Read article

HDL-C to hsCRP ratio is associated with left ventricular diastolic function in absence of significant coronary atherosclerosis

Sun Lufan et al. | Lipids in Health and Disease 2019; 18(1):... Read article

Potentially modifiable blood triglyceride levels by the control of conventional risk factors

Oh Bumjo et al. | Lipids in Health and Disease 2019; 18(1):... Read article

Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease

Dai Wen et al. | Lipids in Health and Disease 2019; 18(1):... Read article

01 - What is new in lipid‐lowering therapies in diabetes?

Yee‐Ming Cheung et al. | Internal Medicine Journal 2019; 49(12):...

Diabetes confers an independent risk to cardiovascular disease (CVD) but also shares many common comorbidities such as hypertension and dyslipidaemia. CVD remains the commonest cause of death in individuals...

Read article

02 - Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without increasing low-density lipoprotein-cholesterol levels: A phase 4, randomized study

Masuda, Daisaku et al. | Atherosclerosis 2019; 292(-): 163-70...

We aimed to investigate blood lipid and lipoprotein profiles in patients with dyslipidemia receiving hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) after 8 weeks of omega-3 fatty acid...

Read article

03 - Effects of intensive lipid-lowering therapy on mortality after coronary bypass surgery: A meta-analysis of 7 randomised trials

Alkhalil et al. | Atherosclerosis 2019; 293(-): 75-8

The recent reported analysis from the ODYSSEY OUTCOMES trial showed that patients with previous coronary bypass graft surgery (CABG) conferred enhanced clinical benefits in response to intensive low-density...

Read article

04 - Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

Brunner, Fabian J et al. | The Lancet 2019; 394(10215): 2173-83...

The relevance of blood lipid concentrations to long-term incidence of cardiovascular disease and the relevance of lipid-lowering therapy for cardiovascular disease outcomes is unclear. We investigated...

Read article

05 - Lipid lowering and Alzheimer disease risk: A mendelian randomization study

Dylan M. Williams PhD et al. | Annals of Neurology 2020; 87(1): 30-9...

There are no preventive or disease‐modifying treatments for Alzheimer disease (AD). Expanding the indications of drugs of proven efficacy into other indications might be an effective strategy to...

Read article

What's new in DyslipidemiaLast update of the site: Tuesday, 21 January 2020

Bibliographical searchFocus and target to your research of scientific data

Top articlesThe 5 most read articles

01 - What is new in lipid‐lowering therapies in diabetes?

02 - Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without increasing low-density lipoprotein-cholesterol levels: A phase 4, randomized study

03 - Effects of intensive lipid-lowering therapy on mortality after coronary bypass surgery: A meta-analysis of 7 randomised trials

04 - Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

05 - Lipid lowering and Alzheimer disease risk: A mendelian randomization study

Usefuls linksWhat else?